Better warfarin therapy for atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a better way to manage warfarin (a blood thinner) for people with atrial fibrillation (an irregular heartbeat). The goal is to improve treatment and help prevent stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must be taking warfarin or have been told you need to start taking it
- You must have atrial fibrillation (a type of irregular heartbeat)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
This trial tests an AI-guided approach to treating atrial fibrillation (AF), a heart rhythm problem. It aims to personalize your treatment plan to better manage symptoms and improve outcomes.
This study looks for unique metabolic patterns in people with atrial fibrillation (an irregular heartbeat). The goal is to develop personalized prevention strategies by comparing these patterns between patients and healthy volunteers.
This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.
This study compares different heart rate targets for people with ongoing atrial fibrillation (an irregular heartbeat) to find which one improves symptoms and quality of life. It may help you and your doctor choose the best treatment plan.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.